The shift in the "paradigm" of the pharmacology of hypertension.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000809:Angiotensins / Q000378:metabolism; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002319:Cardiovascular System / Q000378:metabolism; D004727:Endothelium / Q000187:drug effects / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D010597:Pharmacogenetics; D012084:Renin-Angiotensin System / Q000187:drug effects; D014657:Vasculitis / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000809:Angiotensins; D000959:Antihypertensive Agents; D019204:GTP-Binding Proteins